US Patent Issued to IGC Pharma IP on Dec. 9 for "Compositions and methods using cannabinoids for treating stammering/stuttering and symptoms of Tourette syndrome" (Maryland, Virginia Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,200, issued on Dec. 9, was assigned to IGC Pharma IP LLC (Potomac, Md.).

"Compositions and methods using cannabinoids for treating stammering/stuttering and symptoms of Tourette syndrome" was invented by Ramachandra Mukunda (Potomac, Md.), Jagadeesh Sridhara Rao (Ashburn, Va.) and Amar R. Mukunda (Bethesda, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to compositions and methods for treating stammering/stuttering and Tourette syndrome (TS) in humans, using a formulation comprising of a combination of a Cannabis compound, or compounds."

The patent was filed on May 26, 2020, under Application No. 17/613,909.

*For further ...